LogiPharma 2024

April 16 - 18, 2024

Centre de Congrès de Lyon, France

Mediacenter

The 2024 LogiPharma Playbook

Even in the face of disruptions and uncertainty, the life sciences supply chain continues to grow with many bright new opportunities on the horizon for the taking. As a result, WBR Insights surveyed 150 supply chain leaders in Q4 of 2023 from various organisations and unpack the top challenges currently impacting organisations and the innovative solutions they are bringing to the table.


The 2023 Sustainability Report

How do companies work towards achieving their sustainability targets? In Q3 of 2023, we surveyed 150 Heads of Supply Chain and similar senior executives from the life sciences industry across Europe to better understand the challenges they face in achieving their sustainability targets and the solutions they are bringing to the table.


LogiPharma - The 2023 Playbook

What are the latest challenges and solutions our industry is facing in 2023? Read on and find out! We surveyed 200 Heads of Supply Chain and similar across Europe, the United States, and Canada to find out about the test they are experiencing, and the innovative resolutions being brought to the table.


Transforming Supply Chain Resilience: Leveraging Digital Platforms and Driving Sustainability

In Q4 of 2022, WBR Insights surveyed 100 Heads of Supply Chain and similar across Europe, to find out about the challenges faced in 2022 and the innovative solutions being brought to the table for 2023. Learn how your supply chain peers are working to build resilience against current economic uncertainty and how technology is transforming the pharma supply chain in the wake of COVID-19.


The LogiPharma Playbook - 2022

Pharma and biotech decision-makers today find themselves facing an unprecedented level of logistics and supply chain complexity. Challenges include new weaknesses in global supply chains triggered in part by the COVID-19 pandemic, the increasing importance of demonstrable corporate action on sustainability, and a dramatic uptick in the proportion of pharmaceutical products needing cold-chain treatment.


Building the Supply Chain of the Future: Innovative Strategies for Distribution Channels

In Q1 of 2022, WBR Insights surveyed 200 Heads of Supply Chain and similar across the USA, Canada, and Europe, to find out about the challenges they are facing in 2022 and how they plan to overcome them. The survey was conducted by appointment over the telephone. The results were compiled and anonymized by WBR Insights and are presented here with analysis and commentary by Controlant and the LogiPharma community.


COVID-19: A fast-track learning exercise in innovation

In Q4 of 2021, WBR Insights surveyed 100 Directors of Supply Chain Management and similar from organisations across Europe and North America, to find out about the challenges they are facing in 2021 and the innovative solutions they are putting in place. The survey was conducted by appointment over the telephone.The results were compiled and anonymised by WBR Insights and are presented here with analysis and commentary by Kinaxis, TSS and the LogiPharma community.


Rethinking Pharma Supply Chain Resilience In 2021: How Covid-19 Is Accelerating A Critical Digital Transformation

Never before have pharma supply-chain leaders faced more complex, turbulent conditions than during the COVID-19 pandemic. For many, it has been a crash course in crisis management and a stark warning of the need to build resilience against future shocks. For those in the supply chain, the massive impact on operations has put in sharp relief an industrywide need for change and greater integration of technology for automating workflows and processes. Throughout 2020, the COVID-19 pandemic has caused global economic turmoil and its repercussions will continue ahead. But if there is one silver lining, it is this: the impact of the global pandemic has exposed the top-to-toe fragility of the pharmaceutical supply chain and the need to turn bottlenecks into growth opportunities.


How The Pandemic Is Fast-Forwarding The Shift Towards Autonomous Business Operations

In Q1 of 2021, WBR Insights surveyed 100 supply chain and procurement decision makers from pharmaceutical companies across Europe, to find out about the challenges they are facing in 2021, due to the impact of the COVID-19 pandemic, and the innovative solutions they are putting in place. The survey was conducted by appointment over the telephone. The results were compiled and anonymised by WBR Insights and are presented here with analysis and commentary by Aera Technology and the LogiPharma community.



Want even more reading material? View whitepapers and reports from our 2019 event.

2021 Media Center